Apply

Ready to go for it?

AI Apply speeds things up—apply directly if you prefer.

FREE ACCESS
5,000–10,000 jobs/day
Scoutfield Logo

See all jobs on Scoutfield

Search thousands of fresh jobs every day.

Discover
  • Fresh listings
  • Fast filters
  • No subscription required
Create a free account and start exploring right away.
Weekday (YC W21)

Biotech Investment Analyst – Drug Asset and Company Assessment

Weekday (YC W21)

. Create and critique rubrics that analyze commercial drugs and drug-development programs .

Posted 9/18/2026contractRemote • United StatesMid-LevelSenior💰 $120 - $200 per hourWebsite

Core Competencies

Role fit
Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in evaluating biotech and pharmaceutical assets, including comprehensive assessments of drug development programs and investment theses. Strong analytical skills are essential for critiquing rubrics and improving AI evaluations in the biotech sector.

Highest-signal resume keywords
Biotech Investment AnalysisPharmaceutical Development ProgramsAsset AssessmentClinical Data EvaluationCompetitive Position Analysis

ATS Keywords

Tailor your resume
Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills
Rubric CreationInvestment Thesis EvaluationData AnalysisMarket AssessmentDrug Asset Evaluation
Soft Skills
Critical ThinkingAnalytical SkillsAttention to Detail
Industry Keywords
BiotechHealthcarePharmaInvestment AnalystSpecialist-Fund Background

About the role

Key responsibilities & impact
  • Create and critique rubrics that analyze commercial drugs and drug-development programs
  • Provide overall company and asset assessment, including mechanism, clinical data, competitive position, and value drivers
  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
  • Apply assessments across a pilot set of approximately 5–10 companies
  • Help improve expert AI evaluation of drugs and drug-development programs

Requirements

What you’ll need
  • US-based biotech / healthcare investment analyst with a specialist-fund background
  • Familiarity with biotech/pharma development programs
  • Able to assess a drug asset and the company behind it end-to-end
  • 5+ years evaluating biotech/pharma companies or assets
  • Engagement of approximately 10–20 hours over a 1–2 week pilot
  • Must be based in the United States

Benefits

Comp & perks
  • Paid pilot engagement
  • Potential for recurring engagement for strong contributors